Document Type
Article
Publication Date
2015
Abstract
Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to stem cell patents, focusing on two recent cases, and discuss the future of stem cell patent disputes.
Recommended Citation
16 Cell Stem Cell 461-464 (May 7, 2015)
Included in
Intellectual Property Law Commons, Medical Jurisprudence Commons, Science and Technology Law Commons